SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-040342
Filing Date
2017-08-03
Accepted
2017-08-03 16:34:02
Documents
62
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v471248_10q.htm 10-Q 512317
2 EXHIBIT 31.1 v471248_ex31-1.htm EX-31.1 9798
3 EXHIBIT 31.2 v471248_ex31-2.htm EX-31.2 12683
4 EXHIBIT 32.1 v471248_ex32-1.htm EX-32.1 5913
  Complete submission text file 0001144204-17-040342.txt   4259030

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20170630.xml EX-101.INS 913664
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20170630.xsd EX-101.SCH 40075
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20170630_cal.xml EX-101.CAL 45969
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20170630_def.xml EX-101.DEF 300931
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20170630_lab.xml EX-101.LAB 311263
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20170630_pre.xml EX-101.PRE 327045
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 171005462
SIC: 2834 Pharmaceutical Preparations